Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development
Journal of Microbiology - 2009
Tóm tắt
Shiga toxin 2 (Stx2) is a major virulence factor for enterohemorrhagic Escherichia coli (EHEC), which is encoded by λ lysogenic phage integrated into EHEC chromosome. Stx2Al, Al subunit of Stx2 toxin has gathered extensive concerns due to its potential of being developed into a vaccine candidate. However, the substantial progress is hampered in part for the lack of a suitable in vitro expression system. Here we report use of the prokaryotic system pET-28a::espA-Stx2Al/BL21 to carry out the fusion expression of Stx2Al which is linked to E. coli secreted protein A (EspA) at its N-terminus. Under the IPTG induction, EspA-Stx2Al fusion protein in the form of inclusion body was obtained successfully, whose expression level can reach about 40% of total bacterial protein at 25°C, much higher than that at 37°C. Western blot test suggested the refolded fusion protein is of excellent immuno-reactivity with both monoclonal antibodies, which are specific to EspA and Stx2Al, respectively. Anti-sera from Balb/c mice immunized with the EspA-Stx2Al fusion protein were found to exhibit strong neutralization activity and protection capability in vitro and in vivo. These data have provided a novel feasible method to produce Stx2Al in large scale in vitro, which is implicated for the development of multivalent subunit vaccines candidate against EHEC 0157:H7 infections.
Từ khóa
Tài liệu tham khảo
Akiyoshi, D.E., C.M. Rich, S. O’sullivan-Murphy, L. Richard, J. Dilo, A. Donohue-Rolfe, A.S. Sheoran, S. Chapman-Bonofiglio, and S. Tzipori. 2005. Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells. Infect. Immun. 73, 4054–4061.
Bielaszewska, M., R. Kock, A.W. Friedrich, C. von Eiff, L.B. Zimmerhackl, H. Karch, and A. Mellmann. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS ONE. 2, e1024.
Dziva, F., I. Vlisidou, V.F. Crepin, T.S. Wallis, G. Frankel, and M.P. Stevens. 2007. Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157:H7, induces antigen-specific humoral responses but does not confer protection against intestinal colonisation. Vet. Microbiol. 123, 254–261.
Feng, Y., F. Zheng, X. Pan, W. Sun, C. Wang, Y. Dong, A.P. Ju, J. Ge, D. Liu, C. Liu, J. Yan, J. Tang, and G.F. Gao. 2007. Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis. FEMS Microbiol. Lett. 275, 80–88.
Fraser, M.E., M. Fujinaga, M.M. Cherney, A.R. Melton-Celsa, E.M. Twiddy, A.D. O’Brien, and M.N. James. 2004. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 279, 27511–27517.
Jarvis, K.G. and J.B. Kaper. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64, 4826–4829.
Karmali, M.A., B.T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1, 619–620.
Karpman, D., Z.D. Bekassy, A.C. Sjogren, M.S. Dubois, M.A. Karmali, M. Mascarenhas, K.G. Jarvis, L.J. Gansheroff, A.D. O’Brien, G.S. Arbus, and J.B. Kaper. 2002. Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr. Nephrol. 17, 201–211.
Kato, T., D. Hamada, T. Fukui, M. Hayashi, T. Honda, Y. Murooka, and I. Yanagihara. 2005. A pH-dependent conformational change in EspA, a component of the Escherichia coli O157:H7 type III secretion system. Febs J. 272, 2773–2783.
Kenny, B., L.C. Lai, B.B. Finlay, and M.S. Donnenberg. 1996. EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 20, 313–323.
Kuczius, T., M. Bielaszewska, A.W. Friedrich, and W. Zhang. 2004. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol. Nutr. Food Res. 48, 515–521.
La Ragione, R.M., S. Patel, B. Maddison, M.J. Woodward, A. Best, G.C. Whitelam, and K.C. Gough. 2006. Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro. Microb. Infect. 8, 426–433.
Louise, C.B. and T.G. Obrig. 1992. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60, 1536–1543.
Ma, Y., X. Mao, J. Li, H. Li, Y. Feng, H. Chen, P. Luo, J. Gu, S. Yu, H. Zeng, G. Guo, K. Yang, and Q. Zou. 2008. Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7. Immunol. Lett. 121, 110–115.
Marcato, P., T.P. Griener, G.L. Mulvey, and G.D. Armstrong. 2005. Recombinant shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia. Infect. Immun. 73, 6523–6529.
Marcato, P., G. Mulvey, R.J. Read, K. Vander Helm, P.N. Nation, and G.D. Armstrong. 2001. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. J. Infect. Dis. 183, 435–443.
Matise, I., N.A. Cornick, S.L. Booher, J.E. Samuel, B.T. Bosworth, and H.W. Moon. 2001. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J. Infect. Dis. 183, 347–350.
Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O’Donnell, S.M. Rich, A. Donohue-Rolfe, and S. Tzipori. 2002. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect. Immun. 70, 612–619.
Perna, N.T., G.F. Mayhew, G. Posfai, S. Elliott, M.S. Donnenberg, J.B. Kaper, and F.R. Blattner. 1998. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 66, 3810–3817.
Ran, X.Q., H.Z. Wang, J.J. Liu, S. Li, and J.F. Wang. 2008. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin. Vet. Microbiol. 127, 209–215.
Riley, L.W., R.S. Remis, S.D. Helgerson, H.B. McGee, J.G. Wells, B.R. Davis, R.J. Hebert, E.S. Olcott, L.M. Johnson, N.T. Hargrett, P.A. Blake, and M.L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308, 681–685.
Ritchie, J.M., C.M. Thorpe, A.B. Rogers, and M.K. Waldor. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71, 7129–7139.
Roe, A.J., H. Yull, S.W. Naylor, M.J. Woodward, D.G. Smith, and D.L. Gally. 2003. Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level. Infect. Immun. 71, 5900–5909.
Russmann, H., H. Schmidt, J. Heesemann, A. Caprioli, and H. Karch. 1994. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J. Med. Microbiol. 40, 338–343.
Sekiya, K., M. Ohishi, T. Ogino, K. Tamano, C. Sasakawa, and A. Abe. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 98, 11638–11643.
Takahashi, H., K. Sasaki, M. Takahashi, N. Shigemori, S. Honda, H. Arimitsu, S. Ochi, N. Ohara, and T. Tsuji. 2006. Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette-guerin in mice. Vaccine 24, 3591–3598.
Tarr, P.I., C.A. Gordon, and W.L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073–1086.
Wen, S.X., L.D. Teel, N.A. Judge, and A.D. O’Brien. 2006. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24, 1142–1148.
Yoshimura, K., J. Fujii, A. Tanimoto, T. Yutsudo, M. Kashimura, and S. Yoshida. 2000. Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice. Infect. Immun. 68, 2254–2258.
Yu, S., P. Luo, H.Z. Chen, H.X. Li, and X.H. Mao. 2007. Preparation and characterization of monoclonal antibody against enterohemorrhagic Escherichia coli O157:H7 EspA. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 23, 657–659.
Zhang, W., M. Bielaszewska, T. Kuczius, and H. Karch. 2002. Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans. J. Clin. Microbiol. 40, 1441–1446.